Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02323217Phase 1Completed
Phase 1, open-label trial (3 arms), sponsored by Imperial College London. Primary endpoints: Determination of the Regional Density and Distribution of I2BS in Healthy Human Brain (1TCM Model) at 1 week, Determination of the Regional Density and Distribution of I2BS in Healthy Human Brain (2TCM Model) at 1 week and 1 more. Started Jan 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02323217.